XIAP and leukemia: In fact, the leukemia-associated minor H antigen 1- (HA-1) tgTCR T-cells, restricted to HLA-A*02:01, are used for the most advanced MiHA-based immunotherapy, regarding which further investigations are ongoing (NCT03326921) (246).